Form 4 for ZNTL Zentalis Pharmaceuticals, Inc.
Accepted 2026-02-04 00:00:00 ET · period of report 2026-02-02 · accession 0002018766-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-02-04 | 2026-02-02+ | ZNTL | Vultaggio Vincent | PAO, PFO | S - Sale | $2.54 | -3,096 | 187.3K | -2% | -$7,878 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-03 | S | D | 556 | $2.52 | 186,730 | D | — | — | (F2) This sale was effected pursuant to a Rule 10b5-1 trading arrangement adopted by the Reporting Person. |
| 2 | Common | Common Stock | 2026-02-02 | S | D | 2,540 | $2.55 | 187,286 | D | — | — | (F1) This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. |